Dactolisib suppresses PI3K kinase and mTOR kinase in the PI3K/AKT/mTOR kinase pathway, inducing tumor cell apoptosis and inhibiting growth in PI3K/mTOR highly expressing cancer cells. The gene discussed is AKT1; the disease is neoplasm.